There is important evidence showing that IL-17 has a pleiotropic role in SLE pathology, including defending against pathogen infections, promoting the recruitment of neutrophils and other immune cells, and inducing the production of pro-inflammatory cytokines (60). Here, IL17A is linked to systemic lupus erythematosus.